Quest Diagnostics (DGX) Net Cash Flow (2009 - 2026)

Quest Diagnostics has disclosed Net Cash Flow across 18 years of filings, most recently posting $234.0 million for Q2 2026.

• In Q2 2026, Net Cash Flow rose 84.25% year-over-year to $234.0 million; the TTM figure through Jun 2026 stood at $310.0 million (up 520.0% YoY), while the FY2025 annual figure was -$133.0 million, down 2.31% from the prior year.
• Net Cash Flow came in at $234.0 million for Q2 2026 at Quest Diagnostics, up from -$26.0 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $543.0 million in Q4 2023 to a low of -$385.0 million in Q4 2022.
• Average Net Cash Flow over 5 years is -$13.4 million, with a median of -$37.5 million recorded in 2023.
• Year-over-year, Net Cash Flow slumped 322.22% in 2022 and surged 2800.0% in 2024.
• Over 5 years, Net Cash Flow stood at -$385.0 million in 2022, then surged by 241.04% to $543.0 million in 2023, then slumped by 138.31% to -$208.0 million in 2024, then jumped by 93.75% to -$13.0 million in 2025, then surged by 1900.0% to $234.0 million in 2026.
• Per Business Quant data, the three most recent Net Cash Flow figures were $234.0 million in Q2 2026, -$26.0 million in Q1 2026, and -$13.0 million in Q4 2025.